MedPath

A Prospective Clinical Study On A Total Hip Resurfacing System

Not Applicable
Completed
Conditions
Arthritis
Avascular Necrosis
Interventions
Device: ReCap Total Hip Resurfacing System
Registration Number
NCT00603395
Lead Sponsor
St. Anna Ziekenhuis, Geldrop, Netherlands
Brief Summary

This prospective clinical study is to demonstrate the efficacy and safety of ReCap Total Hip Resurfacing System.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
298
Inclusion Criteria
  • intended for skeletally mature individuals undergoing primary surgery as a result of hip degenerative joint disease, or any composite diagnoses, including:

    • Osteoarthritis
    • Avascular necrosis
    • Traumatic arthritis
    • Legg Perthes
    • Rheumatoid arthritis
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ReCapReCap Total Hip Resurfacing SystemReCap Total Hip Resurfacing System
Primary Outcome Measures
NameTimeMethod
Harris Hip Score, Device Revision/Removal, Radiographic Evaluation2 years postoperative
Secondary Outcome Measures
NameTimeMethod
ComplicationsAnytime

Trial Locations

Locations (1)

Knowledge Center for Orthopedic Surgery, St. Anna hospital

🇳🇱

Geldrop, Netherlands

© Copyright 2025. All Rights Reserved by MedPath